Is a Triggering Role or a Causative Role of PD-1/PDL-1 Inhibitors in the Development of Paraneoplastic Dermatomyositis?
Keywords:
PD-1 inhibitors, dermatomyositis, paraneoplastic, capillaroscopy, breast cancer, immune-related adverse eventsReferences
Messer A, Drozd B, Glitza IC, Lu H, Patel AB. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature. Dermatol Online J. 2020;26(8):13030/qt4c21b068. PMID: 32941716.
Didona D, Fania L, Didona B, Eming R, Hertl M, Di Zenzo G. Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. Int J Mol Sci. 2020;21(6):2178. DOI: 10.3390/ijms21062178. PMID: 32245283; PMCID:PMC7139382.
Published
Issue
Section
License
Copyright (c) 2022 Michela Starace, Francesca Pampaloni, Miriam Anna Carpanese, Giulia Veronesi, Andrea Sechi, Francesca Bruni, Aurora Alessandrini

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

